Sinovac Biotech

A booth displaying a coronavirus vaccine candidate from China National Biotec Group (CNBG), a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm), is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 4, 2020. REUTERS/Tingshu Wang
Coronavirus chronicle

Pakistan approves Chinese Sinopharm Covid-19 vaccine for emergency use

The authorization will be reviewed on quarterly basis for further data regarding safety, efficacy and quality

Officers carry Covid-19 vaccine amid the coronavirus disease (COVID-19) pandemic in Banda Aceh, Aceh Province, Indonesia, January 12, 2021. Ampelsa/Antara Foto via REUTERS
Coronavirus chronicle

Wariness in Indonesia as Chinese Sinovac Covid-19 jabs start

A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter
Coronavirus chronicle

Malaysia's Pharmaniaga buys 14m doses of China's Sinovac Covid vaccine

Sinovac Covid-19 vaccine. Photo/TBS
Coronavirus chronicle

Brazil health regulator says application for Sinovac vaccine lacks information

Sinovac Covid-19 vaccine. Photo/TBS
Bangladesh

Not allowing the Chinese vaccine was the wrong decision: Prof Nazrul

The question arises whether a member state would want to administer to its citizens a vaccine that has not been reviewed by EMA Photo: Collected
World

Chinese vaccine 'successful in mid-stage trials'

Photo :Collected
Coronavirus chronicle

Chinese Covid-19 vaccine starts final tests in Brazil